News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
21,790 Results
Type
Article (842)
Company Profile (1)
Press Release (20947)
Section
Business (6420)
Career Advice (11)
Deals (1333)
Drug Delivery (1)
Drug Development (2895)
FDA (426)
Job Trends (249)
News (11272)
Policy (1062)
Tag
2024 Biotech Beach Standard (1)
Academia (55)
Accelerated approval (1)
Allergies (8)
Alliances (2139)
ALS (4)
Alzheimer's disease (28)
Antibody-drug conjugate (ADC) (7)
Approvals (440)
Artificial intelligence (8)
Autoimmune disease (2)
Automation (1)
Bankruptcy (6)
Best Places to Work (197)
Biosimilars (3)
Biotechnology (3)
Bladder cancer (6)
Brain cancer (1)
Breast cancer (11)
Cancer (86)
Cardiovascular disease (3)
Career advice (10)
CAR-T (4)
Cell therapy (13)
Clinical research (2417)
Collaboration (30)
Compensation (10)
COVID-19 (115)
CRISPR (2)
C-suite (8)
Cystic fibrosis (4)
Data (88)
Denatured (2)
Diabetes (7)
Diagnostics (150)
Digital health (3)
Drug discovery (3)
Drug pricing (1)
Drug shortages (1)
Duchenne muscular dystrophy (3)
Earnings (2395)
Events (2551)
Executive appointments (22)
FDA (489)
Funding (22)
Gene editing (3)
Gene therapy (15)
GLP-1 (12)
Government (137)
Grass and pollen (1)
Guidances (4)
Healthcare (728)
IgA nephropathy (3)
Immunology and inflammation (1)
Indications (5)
Infectious disease (121)
Inflammatory bowel disease (4)
Influenza (1)
Intellectual property (3)
Interviews (2)
IPO (476)
Job creations (71)
Job search strategy (10)
Kidney cancer (3)
Layoffs (8)
Legal (208)
Lung cancer (17)
Lymphoma (11)
Manufacturing (16)
MASH (2)
Medical device (413)
Medtech (413)
Mergers & acquisitions (878)
Metabolic disorders (14)
Multiple sclerosis (4)
Neurodegenerative disease (1)
Neuroscience (45)
NextGen: Class of 2025 (87)
Non-profit (61)
Northern California (69)
Obesity (4)
Opinion (1)
Ovarian cancer (3)
Pancreatic cancer (4)
Parkinson's disease (7)
Patents (6)
Patient recruitment (6)
Peanut (5)
People (1739)
Pharmaceutical (1)
Phase I (716)
Phase II (1056)
Phase III (875)
Pipeline (54)
Podcasts (2)
Postmarket research (66)
Preclinical (298)
Press Release (3)
Prostate cancer (6)
Radiopharmaceuticals (11)
Rare diseases (11)
Real estate (160)
Regulatory (806)
Reports (1)
Research institute (49)
Schizophrenia (1)
Series A (4)
Series B (5)
Southern California (93)
Spinal muscular atrophy (3)
Sponsored (1)
Startups (108)
Supply chain (3)
United States (446)
Vaccines (46)
Venture capitalists (2)
Women's health (2)
Date
Today (3)
Last 7 days (25)
Last 30 days (111)
Last 365 days (1289)
2025 (326)
2024 (1276)
2023 (1421)
2022 (2570)
2021 (2510)
2020 (1730)
2019 (1144)
2018 (938)
2017 (1220)
2016 (938)
2015 (1066)
2014 (844)
2013 (652)
2012 (709)
2011 (810)
2010 (745)
Location
Africa (35)
Arizona (2)
Asia (824)
Australia (167)
California (174)
Canada (43)
China (13)
Colorado (1)
Connecticut (1)
Delaware (4)
Europe (9680)
Florida (7)
Georgia (3)
Idaho (4)
Illinois (11)
India (3)
Indiana (8)
Japan (7)
Maine (1)
Maryland (17)
Massachusetts (100)
Michigan (5)
Minnesota (10)
New Jersey (31)
New Mexico (1)
New York (26)
North Carolina (16)
Northern California (69)
Ohio (2)
Oregon (1)
Pennsylvania (13)
South America (151)
Southern California (93)
Tennessee (6)
Texas (6)
Virginia (2)
Washington D.C. (1)
Washington State (3)
21,790 Results for "carmat sas".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
LimmaTech Vaccinates First Participants in Phase 1 Study of Staphylococcus aureus Vaccine Candidate LBT-SA7
February 17, 2025
·
4 min read
RELIEF THERAPEUTICS Holding SA Announces Results of Annual General Meeting
RELIEF THERAPEUTICS Holding SA announces the results of its annual general meeting (AGM) of shareholders, which took place in Geneva today.
June 27, 2024
·
3 min read
Press Releases
Acquisition of Ovizio Imaging Systems SA
October 17, 2024
·
1 min read
Deals
Stryker completes acquisition of SERF SAS
Stryker (NYSE: SYK), a leading global medical technology company, announced today that it has completed the previously announced acquisition of SERF SAS, a France -based joint replacement company, from Menix.
March 21, 2024
·
4 min read
RELIEF THERAPEUTICS Holding SA Announces Results of Extraordinary General Meeting
RELIEF THERAPEUTICS Holding SA announces the results of the extraordinary general meeting of shareholders, which took place in Geneva , Friday, April 26, 2024.
April 26, 2024
·
4 min read
Business
ExcellGene SA and Cytovance Biologics Join Forces to Transform Large Molecule Biologics Development and Manufacture
ExcellGene SA proudly announces its strategic collaboration with Cytovance Biologics, a renowned Contract Development and Manufacturing Organization based in the USA.
May 8, 2024
·
3 min read
Heart Failure Patients Take Heart as Carmat’s Bioprosthetic Implanted into First Woman
French artificial heart maker Carmat announced Tuesday that it had successfully implanted its Aeson artificial heart into the chest cavity of a 57-year-old woman.
September 21, 2021
·
2 min read
·
Heather McKenzie
Press Releases
ChemoMetec makes offer to buy Ovizio Imaging Systems SA
September 23, 2024
·
1 min read
Press Releases
BioSenic S.A. : Transparency notification received from ABO Infinium Americas OpCo LTD.
October 7, 2024
·
5 min read
Press Releases
Rejuvenate Biomed and SAS tap AI to develop disease-agnostic drug repurposing discovery tools
August 1, 2024
·
3 min read
1 of 2,179
Next
